Systematic Financial Management’s ANI Pharmaceuticals ANIP Stock Holding History

Systematic Financial Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,716	Closed	-$68.2K	–	240
2023 Q1	$68.2K	Buy	+1,716	New	+$72.4K	﹤0.01%	287
2020 Q3	–	Sell	-10,185	Closed	-$329K	–	260
2020 Q2	$329K	Buy	10,185 +930	+10%	+$33.3K	0.02%	270
2020 Q1	$377K	Sell	9,255 -890	-9%	-$47.3K	0.02%	236
2019 Q4	$626K	Buy	10,145 +2,895	+40%	+$192K	0.02%	306
2019 Q3	$528K	Sell	7,250 -5,645	-44%	-$422K	0.02%	366
2019 Q2	$1.06M	Buy	+12,895	New	+$917K	0.04%	255

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Systematic Financial Management's ANIP Position: Q2 2023 in Review

Systematic Financial Management sold out of ANI Pharmaceuticals (ANIP) in Q2 2023, closing a stake of 1,716 shares — an estimated $68.2K sold.

Systematic Financial Management first reported a position in ANIP in Q2 2019 and held it in 6 quarters. The position peaked at $1.06M in Q2 2019. 171 funds tracked by Wall St. Rank hold ANIP as of Q2 2023.

Systematic Financial Management reported no remaining ANI Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Systematic Financial Management sold 1,716 ANI Pharmaceuticals shares in Q2 2023, an estimated $68.2K.
Systematic Financial Management first reported a position in ANI Pharmaceuticals in Q2 2019 and held it in 6 quarters.
Systematic Financial Management's ANI Pharmaceuticals position peaked at $1.06M in Q2 2019.
171 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2023.

Based on Systematic Financial Management's 13F filing for Q2 2023, filed 14 Aug 2023.